Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics adjourns special meeting again; vote reconvenes Nov. 12, 2026

Neutral Impact 3 of 5 shareholder Written later

Tempest Therapeutics said its reconvened special meeting of stockholders lacked sufficient votes to approve a charter amendment that would replace specified supermajority voting requirements and permit stockholder action by written consent, so the meeting was adjourned again. The meeting will reconvene on November 12, 2026, and the proposal still requires at least 75% of the votes stockholders could cast in director elections, which matters because approval would change how shareholders can act.

Key points

  • Quorum was reached with 11,004,101 shares, or 74.3% of the 14,806,997 shares outstanding as of the May 28, 2026 record date, present or represented by proxy.
  • The proposal requires the affirmative vote of at least 75% of the votes all stockholders could cast in an annual election of directors.
  • The special meeting will reconvene on November 12, 2026, at 2:00 p.m. Eastern Time by live webcast.
  • The company has engaged Sodali & Co., a proxy solicitation firm, to help obtain sufficient votes.

The filing

CompanyTempest Therapeutics, Inc. (TPST)
Form8-K, current report
Filed with the SECOct 20, 2026, 4:06 PM ET
Accession number0001213900-26-111026

Items reported: 5.07 Shareholder Vote Results8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.